AU2002227931A1 - Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as medicament, and pharmaceutical preparations containing these compounds - Google Patents

Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as medicament, and pharmaceutical preparations containing these compounds

Info

Publication number
AU2002227931A1
AU2002227931A1 AU2002227931A AU2002227931A AU2002227931A1 AU 2002227931 A1 AU2002227931 A1 AU 2002227931A1 AU 2002227931 A AU2002227931 A AU 2002227931A AU 2002227931 A AU2002227931 A AU 2002227931A AU 2002227931 A1 AU2002227931 A1 AU 2002227931A1
Authority
AU
Australia
Prior art keywords
substituted
compounds
ortho
meta
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002227931A
Other versions
AU2002227931B2 (en
Inventor
Joachim Brendel
Horst Hemmerle
Heinz-Werner Kleemann
Stefan Peukert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10059418A external-priority patent/DE10059418A1/en
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Publication of AU2002227931A1 publication Critical patent/AU2002227931A1/en
Assigned to SANOFI-AVENTIS DEUTSCHLAND GMBH reassignment SANOFI-AVENTIS DEUTSCHLAND GMBH Request for Assignment Assignors: AVENTIS PHARMA DEUTSCHLAND GMBH
Application granted granted Critical
Publication of AU2002227931B2 publication Critical patent/AU2002227931B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002227931A 2000-11-30 2001-11-17 Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as medicament, and pharmaceutical preparations containing these compounds Ceased AU2002227931B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10059418.2 2000-11-30
DE10059418A DE10059418A1 (en) 2000-11-30 2000-11-30 Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicaments and pharmaceutical preparations containing them
PCT/EP2001/013294 WO2002044137A1 (en) 2000-11-30 2001-11-17 Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds

Publications (2)

Publication Number Publication Date
AU2002227931A1 true AU2002227931A1 (en) 2002-08-15
AU2002227931B2 AU2002227931B2 (en) 2006-07-13

Family

ID=7665215

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002227931A Ceased AU2002227931B2 (en) 2000-11-30 2001-11-17 Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as medicament, and pharmaceutical preparations containing these compounds
AU2793102A Pending AU2793102A (en) 2000-11-30 2001-11-17 Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2793102A Pending AU2793102A (en) 2000-11-30 2001-11-17 Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds

Country Status (29)

Country Link
US (2) US6605625B2 (en)
EP (1) EP1339675B1 (en)
JP (1) JP4051283B2 (en)
KR (1) KR100968056B1 (en)
CN (1) CN1290825C (en)
AR (1) AR031430A1 (en)
AT (1) ATE289292T1 (en)
AU (2) AU2002227931B2 (en)
BR (1) BR0115769A (en)
CA (1) CA2430273C (en)
CZ (1) CZ301631B6 (en)
DE (2) DE10059418A1 (en)
EE (1) EE05240B1 (en)
ES (1) ES2236341T3 (en)
HK (1) HK1061231A1 (en)
HR (1) HRP20030436B1 (en)
HU (1) HUP0303317A3 (en)
IL (2) IL156097A0 (en)
MX (1) MXPA03004386A (en)
NO (1) NO328599B1 (en)
NZ (1) NZ526177A (en)
PL (1) PL206245B1 (en)
PT (1) PT1339675E (en)
RS (1) RS50403B (en)
RU (1) RU2278858C2 (en)
SK (1) SK286708B6 (en)
TW (1) TWI254039B (en)
WO (1) WO2002044137A1 (en)
ZA (1) ZA200303893B (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10060807A1 (en) * 2000-12-07 2002-06-20 Aventis Pharma Gmbh Ortho, ortho-substituted nitrogen-containing bisaryl compounds, processes for their preparation, their use as medicaments and pharmaceutical preparations containing them
GB0124936D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124934D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124938D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124941D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124931D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124933D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124939D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
PL212910B1 (en) * 2002-02-12 2012-12-31 Smithkline Beecham Corp Nicotinamide derivates useful as p38 inhibitors
GB0217757D0 (en) 2002-07-31 2002-09-11 Glaxo Group Ltd Novel compounds
AU2003258630A1 (en) 2002-08-19 2004-03-11 Glaxo Group Limited Pyrimidine derivatives as selective cox-2 inhibitors
GB0221443D0 (en) 2002-09-16 2002-10-23 Glaxo Group Ltd Pyridine derivates
ES2571779T3 (en) * 2002-12-13 2016-05-26 Ym Biosciences Australia Pty Nicotinamide-based kinase inhibitors
CA2508171C (en) * 2002-12-13 2012-08-28 Cytopia Pty Ltd Nicotinamide-based kinase inhibitors
AU2003291839B2 (en) * 2002-12-13 2009-01-22 Ym Biosciences Australia Pty Ltd Nicotinamide-based kinase inhibitors
GB0308185D0 (en) * 2003-04-09 2003-05-14 Smithkline Beecham Corp Novel compounds
GB0315950D0 (en) 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
DE10341233A1 (en) * 2003-09-08 2005-03-24 Aventis Pharma Deutschland Gmbh Composition, useful to treat e.g. atrial fibrillation, atrial flutter and atrial arrhythmia, comprises at least one beta-blocker and at least one compound of a phenylcarboxylic acid amide derivative
US20050054673A1 (en) * 2003-09-08 2005-03-10 Aventis Pharma Deutschland Gmbh Combination of phenylcarboxylic acid amides with beta-adrenoreceptor blockers and their use for the treatment of atrial arrhythmias
US7691879B2 (en) * 2003-09-23 2010-04-06 Merck Sharp & Dohme Corp. Isoquinoline potassium channel inhibitors
US7647300B2 (en) * 2004-01-26 2010-01-12 Google Inc. Methods and systems for output of search results
GB0402143D0 (en) * 2004-01-30 2004-03-03 Smithkline Beecham Corp Novel compounds
GB0403744D0 (en) * 2004-02-20 2004-03-24 Astrazeneca Ab Chemical process
JP2007528420A (en) * 2004-03-11 2007-10-11 グラクソ　グループ　リミテッド Novel M3 muscarinic acetylcholine receptor antagonist
GB0412986D0 (en) 2004-06-10 2004-07-14 Xention Discovery Ltd Compounds
CN1993348A (en) * 2004-07-29 2007-07-04 默克公司 Potassium channel inhibitors
US7569589B2 (en) 2004-07-29 2009-08-04 Merck & Co., Inc. Potassium channel inhibitors
US20080051416A1 (en) * 2004-10-05 2008-02-28 Smithkline Beecham Corporation Novel Compounds
US7932247B2 (en) 2004-11-15 2011-04-26 Glaxo Group Limited M3 muscarinic acetylcholine receptor antagonists
US7576212B2 (en) 2004-12-09 2009-08-18 Xention Limited Thieno[2,3-B] pyridines as potassium channel inhibitors
GB0512429D0 (en) * 2005-06-17 2005-07-27 Smithkline Beecham Corp Novel compound
AU2006276292B2 (en) * 2005-07-22 2010-09-16 Merck Sharp & Dohme Corp. Potassium channel inhibitors
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
NZ572231A (en) * 2006-04-27 2010-12-24 Sanofi Aventis Deutschland Inhibitors of the task-1 and task-3 ion channel
TW200845991A (en) 2007-01-12 2008-12-01 Smithkline Beecham Corp N-substituted glycine derivatives: hydroxylase inhibitors
CL2008000986A1 (en) * 2007-04-06 2008-10-17 Neurocrine Biosciences Inc COMPOUND DERIVED FROM NITROGEN HETEROCICLES, GnRH RECEPTOR AGONISTS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE TO TREAT AN AFFECTION RELATED TO SEX HORMONES, ENDOMETRIOSIS, DISMENORREA, OV DISEASE
PA8775801A1 (en) 2007-04-06 2009-05-15 Neurocrine Biosciences Inc ANTIGONIST OF THE RECEIVER OF GONADOTROPINE LIBERATING HORMONE AND PROCEDURES RELATED TO THEMSELVES
GB0815782D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815784D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815781D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB201105659D0 (en) 2011-04-01 2011-05-18 Xention Ltd Compounds
NO3175985T3 (en) 2011-07-01 2018-04-28
CA2862670A1 (en) 2012-01-27 2013-08-01 Gilead Sciences, Inc. Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
TWI773657B (en) 2015-12-18 2022-08-11 美商亞德利克斯公司 Substituted 4-phenyl pyridine compounds as non-systemic tgr5 agonists
CN107573292B (en) * 2017-09-04 2022-06-24 江苏艾立康医药科技有限公司 Pyrazine derivatives acting on prolyl hydroxylase

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19675036I2 (en) * 1990-02-19 2004-10-21 Novartis Ag Acyl compounds.
GB9220137D0 (en) * 1992-09-23 1992-11-04 Pfizer Ltd Therapeutic agents
WO1995001326A1 (en) * 1993-06-30 1995-01-12 The Wellcome Foundation Limited Anti-atherosclerotic diaryl compounds
GB9416972D0 (en) * 1994-08-23 1994-10-12 Smithkline Beecham Plc Carbon side chain/indole/indolene
DE4430638A1 (en) * 1994-08-29 1996-03-07 Bayer Ag Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as a medicament
DE4432101A1 (en) * 1994-09-09 1996-03-14 Hoechst Ag Amino acid-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them
US5670504A (en) 1995-02-23 1997-09-23 Merck & Co. Inc. 2,6-diaryl pyridazinones with immunosuppressant activity
US6083986A (en) * 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
US5935945A (en) 1996-10-31 1999-08-10 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
US5969017A (en) 1996-10-31 1999-10-19 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
KR100241350B1 (en) * 1997-10-27 2000-02-01 정선종 Electronic certificate paper generation method
US6333337B1 (en) * 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
JP2002523451A (en) * 1998-09-01 2002-07-30 ブリストル−マイヤーズ スクイブ カンパニー Potassium channel inhibitors and methods
WO2000015603A1 (en) * 1998-09-11 2000-03-23 Ajinomoto Co., Inc. Benzene derivatives and medicinal use thereof
DE19947457A1 (en) * 1999-10-02 2001-04-05 Aventis Pharma Gmbh New 2'-aminomethyl-biphenyl-2-carboxamide derivatives, are potassium channel blockers especially useful for treating re-entry or supraventricular arrhythmia or atrial fibrillation or flutter

Similar Documents

Publication Publication Date Title
AU2002227931A1 (en) Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as medicament, and pharmaceutical preparations containing these compounds
IL156097A0 (en) Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds
HK1047575A1 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same.
IL148870A (en) 2'-substituted 1,1'-biphenyl - 2 - carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
HRP20010115B1 (en) Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
AU2001284021A1 (en) Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof
HUP0400200A3 (en) Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof
AU2001262221A1 (en) Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use
AU2001241056A1 (en) Spiro compounds, process for preparing the same and use thereof as drugs
HUP0203496A3 (en) Novel cyclopropane derivatives, pharmaceutical compositions containing them and method for the production thereof
WO2001010816A3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives
AU777185C (en) Pharmaceutical form of administration for peptides, methods for its production and use
AU2001234107A1 (en) Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
AU2001292331A1 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU2001292331A2 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU3825700A (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
IL145041A0 (en) Novel morpholine derivatives, methods for the production thereof and pharmaceutical preparations containing said derivatives
ZA200300777B (en) Process for the preparation of peptide salts, their use and pharmaceutical preparations comprising the peptide salts.
AU2227401A (en) 5-thia-omega-(substituted phenyl)-prostaglandin e alcohols, process for preparing the alcohols and pharmaceutical preparations containing the same as the activeingredient
AU2001260083A1 (en) New pharmaceutical composition and the process for its preparation
AU2001274000A1 (en) Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
AU2001241067A1 (en) Omega-substituted phenyl-prostaglandin e-alcohols, process for producing the same and drugs containing the same as the active ingredient
AU2090900A (en) Novel gymnemic acid derivatives, process for the preparation thereof and use thereof as medicine
AU1021001A (en) Cyclic biphenyls, method for the production thereof, and their use as medicaments
AU2000249111A1 (en) New pharmaceutical composition and the process for its preparation